Biomarin Pharmaceutical Inc (BMRN)
Net profit margin
| Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | 520,417 | 657,241 | 523,883 | 426,859 | 322,291 | 256,589 | 205,455 | 167,645 | 147,021 | 99,991 | 71,615 | 141,561 | 83,912 | 54,070 | 39,347 | -64,080 | 15,917 | 837,214 | 795,090 | 859,100 |
| Revenue (ttm) | US$ in thousands | 3,094,001 | 3,063,608 | 2,950,227 | 2,853,915 | 2,752,809 | 2,588,398 | 2,471,644 | 2,419,226 | 2,310,557 | 2,234,572 | 2,173,095 | 2,096,039 | 2,008,311 | 1,911,709 | 1,879,604 | 1,846,275 | 1,848,588 | 1,916,630 | 1,844,422 | 1,860,435 |
| Net profit margin | 16.82% | 21.45% | 17.76% | 14.96% | 11.71% | 9.91% | 8.31% | 6.93% | 6.36% | 4.47% | 3.30% | 6.75% | 4.18% | 2.83% | 2.09% | -3.47% | 0.86% | 43.68% | 43.11% | 46.18% |
September 30, 2025 calculation
Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $520,417K ÷ $3,094,001K
= 16.82%
Peer comparison
Sep 30, 2025
Company name
Symbol
Net profit margin
Biomarin Pharmaceutical Inc
BMRN
16.82%
Arrowhead Pharmaceuticals Inc
ARWR
-0.20%
Regeneron Pharmaceuticals Inc
REGN
32.13%